I DIDN'T KNOW WHETHER to laugh, cry, or bang my head against the wall after most of the interviews I did for this issue's cover story (see page 38). Are we really looking at just a few bad apples, or has the whole barrel gone rotten on us when it comes to the integrity of clinical research data? As example after example washed over me — such as the recent suppression of data about the adverse effects of antidepressants and anti-inflammatory pain medications, and the cases of ghost-written ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.